Is Anebulo Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: ANEB) stock is to Strong Buy ANEB stock.
Out of 3 analysts, 1 (33.33%) are recommending ANEB as a Strong Buy, 2 (66.67%) are recommending ANEB as a Buy, 0 (0%) are recommending ANEB as a Hold, 0 (0%) are recommending ANEB as a Sell, and 0 (0%) are recommending ANEB as a Strong Sell.
According to 3 Wall Street analysts that have issued a 1 year ANEB price target, the average ANEB price target is $6.67, with the highest ANEB stock price forecast at $8.00 and the lowest ANEB stock price forecast at $6.00.
On average, Wall Street analysts predict that Anebulo Pharmaceuticals's share price could reach $6.67 by Sep 21, 2024. The average Anebulo Pharmaceuticals stock price prediction forecasts a potential upside of 103.26% from the current ANEB share price of $3.28.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.